A SCID mouse model for human immune response and disease (Q40497118)

21 September 2017

1 reference

title

A SCID mouse model for human immune response and disease (English)

1 reference

21 September 2017

N Hozumi

1

1 reference

21 September 2017

R Gorczynski

series ordinal

2

1 reference

21 September 2017

W Peters

series ordinal

3

1 reference

21 September 2017

J S Sandhu

series ordinal

4

1 reference

21 September 2017

1 June 1994

1 reference

21 September 2017

Research in Immunology

1 reference

21 September 2017

145

1 reference

21 September 2017

5

1 reference

21 September 2017

370-379

1 reference

Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Timing, genetic requirements and functional consequences of somatic hypermutation during B-cell development.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

The development of B cells and the B-cell repertoire in the microenvironment of the germinal center

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

A severe combined immunodeficiency mutation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Immunization of hu-PBL–SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Transfer of a functional human immune system to mice with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versushost disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

Evidence for early Th 2 T cell predominance in xenoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2894%2980202-5

7 January 2021

10.1016/S0923-2494(94)80202-5

Identifiers

DOI

1 reference

21 September 2017

1 reference